|
業務類別
|
Biotechnology |
|
業務概覽
|
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers. |
| 公司地址
| 1000 Skokie Boulevard, Suite 350, Wilmette, IL, USA, 60091 |
| 電話號碼
| +1 847 388-0349 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.monopartx.com |
| 員工數量
| 16 |
| Dr. Patrice P. Rioux,M.D.,PhD |
Acting Chief Medical Officer |
-- |
30/04/2025 |
| Mr. Quan Anh Vu |
Chief Financial Officer and Principal Accounting Officer |
-- |
03/03/2025 |
| Dr. Chandler D. Robinson, M. Sc.,M.B.A.,M.D. |
Chief Executive Officer and Director |
美元 603.20K |
30/04/2025 |
| Mr. Andrew J. Cittadine |
Chief Operating Officer |
美元 384.80K |
30/04/2025 |
|
|
| Mr. Arthur J. Klausner, M.B.A. |
Independent Director |
30/04/2025 |
| Dr. Christopher M. Starr,PhD |
Executive Chairman of the Board |
30/04/2025 |
| Ms. Kim R. Tsuchimoto |
Director |
30/04/2025 |
| Mr. Raymond William Anderson, M.B.A.,M.S. |
Independent Director |
30/04/2025 |
| Dr. Chandler D. Robinson, M. Sc.,M.B.A.,M.D. |
Chief Executive Officer and Director |
30/04/2025 |
| Ms. Lavina Talukdar, C.F.A. |
Independent Director |
24/02/2025 |
|
|
|
|
